Back to Resources
Market Highlights
-
Press releases announced approval status updates for breast cancer. AstraZeneca and Daiichi Sankyo also discussed recent developments for their financial results, portfolios, and pipelines.
-
Readers were informed that the first patient was dosed in a lung cancer study, and touted updated NCCN Guidelines recommending Datroway.
Questions about this SnapShot or other markets?
U.S. MARKETS
Christine Alongi
alongi@dtwresearch.com
GLOBAL MARKETS
Robin Cefalo
cefalo@dtwresearch.com
SOCIAL MEDIA MARKETS
Andrew Carney
carney@dtwresearch.com